EA201891222A1 - Производные иминотетрагидропиримидинона в качестве ингибиторов плазмепсина v - Google Patents
Производные иминотетрагидропиримидинона в качестве ингибиторов плазмепсина vInfo
- Publication number
- EA201891222A1 EA201891222A1 EA201891222A EA201891222A EA201891222A1 EA 201891222 A1 EA201891222 A1 EA 201891222A1 EA 201891222 A EA201891222 A EA 201891222A EA 201891222 A EA201891222 A EA 201891222A EA 201891222 A1 EA201891222 A1 EA 201891222A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- derivatives
- plasmexin
- iminotetrahydropyrimidinon
- inhibitors
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
В заявке описана серия производных 2-имино-6-метилтетрагидропиримидин-4(1H)-она, замещенных в положении 6 фенильным фрагментом, который, в свою очередь, является замещенным в мета-положении необязательно замещенной ненасыщенной конденсированной бициклической кольцевой системой, содержащей по меньшей мере один атом азота, являющихся селективными ингибиторами активности плазмепсина V, полезных для применения в качестве фармацевтических средств, в особенности для лечения малярии.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1520808.5A GB201520808D0 (en) | 2015-11-25 | 2015-11-25 | Therapeutic agents |
GBGB1612944.7A GB201612944D0 (en) | 2016-07-26 | 2016-07-26 | Therapeutic agents |
PCT/EP2016/078664 WO2017089453A1 (en) | 2015-11-25 | 2016-11-24 | Iminotetrahydropyrimidinone derivatives as plasmepsin v inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201891222A1 true EA201891222A1 (ru) | 2018-10-31 |
EA034196B1 EA034196B1 (ru) | 2020-01-16 |
Family
ID=57391986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201891222A EA034196B1 (ru) | 2015-11-25 | 2016-11-24 | Производные иминотетрагидропиримидинона в качестве ингибиторов плазмепсина v |
Country Status (8)
Country | Link |
---|---|
US (1) | US11136310B2 (ru) |
EP (1) | EP3380464B1 (ru) |
JP (1) | JP6826116B2 (ru) |
CN (1) | CN108290860B (ru) |
CA (1) | CA3005809A1 (ru) |
EA (1) | EA034196B1 (ru) |
ES (1) | ES2811329T3 (ru) |
WO (1) | WO2017089453A1 (ru) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10793563B2 (en) | 2018-01-29 | 2020-10-06 | Merck Patent Gmbh | GCN2 inhibitors and uses thereof |
GB201805816D0 (en) | 2018-04-06 | 2018-05-23 | Ucb Biopharma Sprl | Therapeutic agents |
EA202190952A1 (ru) | 2018-10-05 | 2021-12-22 | Аннапурна Байо, Инк. | Соединения и композиции для лечения патологических состояний, связанных с активностью рецептора apj |
GB201906804D0 (en) | 2019-05-14 | 2019-06-26 | Ucb Biopharma Sprl | Therapeutic agents |
WO2021026884A1 (en) * | 2019-08-15 | 2021-02-18 | Merck Sharp & Dohme Corp. | Antimalarial agents |
CA3141524A1 (en) | 2019-08-19 | 2021-02-25 | UCB Biopharma SRL | Antimalarial hexahydropyrimidine analogues |
CN110642720B (zh) * | 2019-10-12 | 2022-09-27 | 浙江吉泰新材料股份有限公司 | 一种2,4-二氟-3,5-二氯硝基苯的制备方法 |
WO2021155612A1 (en) * | 2020-02-09 | 2021-08-12 | Merck Sharp & Dohme Corp. | Antimalarial agents |
GB202010606D0 (en) | 2020-07-10 | 2020-08-26 | Ucb Biopharma Sprl | Therapeutic agents |
WO2023102747A1 (en) * | 2021-12-07 | 2023-06-15 | Merck Sharp & Dohme Llc | Antimalarial agents |
CN113717053B (zh) * | 2021-09-02 | 2023-10-27 | 合肥利夫生物科技有限公司 | 一种酪氨酸激酶抑制剂关键中间体的合成方法 |
WO2023152042A1 (en) | 2022-02-08 | 2023-08-17 | UCB Biopharma SRL | Antimalarial hexahydropyrimidine analogues |
CN114591338B (zh) * | 2022-03-31 | 2023-05-09 | 苏州欧康维视生物科技有限公司 | 一种Syk和VEGFR2双靶点抑制剂的制备方法及其用途 |
EP4434972A1 (en) * | 2023-03-22 | 2024-09-25 | Eberhard-Karls-Universität Tübingen | Atm kinase inhibitors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7592348B2 (en) | 2003-12-15 | 2009-09-22 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
PT1699455E (pt) * | 2003-12-15 | 2013-08-27 | Merck Sharp & Dohme | Inibidores de protease de aspartilo heterocíclicos |
EP1802588A4 (en) * | 2004-10-15 | 2010-02-17 | Astrazeneca Ab | SUBSTITUTED AMINOPYRIMIDONE AND APPLICATIONS THEREOF |
JP2008516945A (ja) * | 2004-10-15 | 2008-05-22 | アストラゼネカ・アクチエボラーグ | 置換されたアミノ化合物およびそれらの使用 |
AR058381A1 (es) * | 2005-12-19 | 2008-01-30 | Astrazeneca Ab | Compuestos derivados de 2-aminopiridin-4-onas y una composicion farmaceutica |
RU2009100074A (ru) * | 2006-06-12 | 2010-07-20 | Шеринг Корпорейшн (US) | Гетероциклические ингибиторы аспартильной протеазы |
-
2016
- 2016-11-24 EA EA201891222A patent/EA034196B1/ru not_active IP Right Cessation
- 2016-11-24 JP JP2018526893A patent/JP6826116B2/ja active Active
- 2016-11-24 WO PCT/EP2016/078664 patent/WO2017089453A1/en active Application Filing
- 2016-11-24 EP EP16800984.3A patent/EP3380464B1/en active Active
- 2016-11-24 CA CA3005809A patent/CA3005809A1/en active Pending
- 2016-11-24 CN CN201680068950.5A patent/CN108290860B/zh active Active
- 2016-11-24 US US15/774,332 patent/US11136310B2/en active Active
- 2016-11-24 ES ES16800984T patent/ES2811329T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
BR112018010473A8 (pt) | 2019-02-26 |
EP3380464B1 (en) | 2020-05-27 |
CN108290860A (zh) | 2018-07-17 |
CN108290860B (zh) | 2021-08-10 |
WO2017089453A1 (en) | 2017-06-01 |
JP6826116B2 (ja) | 2021-02-03 |
EA034196B1 (ru) | 2020-01-16 |
ES2811329T3 (es) | 2021-03-11 |
EP3380464A1 (en) | 2018-10-03 |
US20200283416A1 (en) | 2020-09-10 |
BR112018010473A2 (pt) | 2018-11-21 |
US11136310B2 (en) | 2021-10-05 |
CA3005809A1 (en) | 2017-06-01 |
JP2019501138A (ja) | 2019-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201891222A1 (ru) | Производные иминотетрагидропиримидинона в качестве ингибиторов плазмепсина v | |
EA201891870A1 (ru) | Производные иминотиадиазинандиоксида в качестве ингибиторов плазмепсина v | |
CY1120988T1 (el) | Παρεμποδιστες διαρυλ κινασης | |
BR112017024917A2 (pt) | síntese de compostos heterocíclicos | |
ECSP16067303A (es) | Heteroarilos y usos de estos | |
EA201890749A1 (ru) | ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ (ACC) И ИХ ПРИМЕНЕНИЕ | |
MD3428170T2 (ro) | Derivat de piridonă policiclică anti-gripal și promedicament al acestuia | |
MX2017006266A (es) | Compuestos de heteroarilo como inhibidores de cinasas asociadas al receptor de interleucina 1(irak) y sus usos. | |
DOP2017000178A (es) | Inhibidores selectivos de bace1 | |
CL2014002880A1 (es) | Compuestos derivados de heterociclos nitrogenados o sus sales, inhibidores selectivos de la pde2a; medicamento que los comprende; y su uso para la profilaxis y tratamiento de la esquizofrenia. | |
EA201691512A1 (ru) | Бензохинолиновые ингибиторы везикулярного переносчика моноамина 2 | |
EA201792021A1 (ru) | Ингибитор jak | |
MA43120A (fr) | Dérivé tricyclique contenant de l'azote présentant une activité inhibitrice de la réplication du vih | |
RS54730B1 (sr) | Inhibitori beta sekretaze | |
EA201790016A1 (ru) | АНАЛОГ ПИРИДИНО[1,2-a]ПИРИМИДОНА, ПРИМЕНЯЕМЫЙ В КАЧЕСТВЕ ИНГИБИТОРА PI3K | |
CY1122423T1 (el) | Παραγωγα πυριμιδινης χρησιμα ως εκλεκτικοι αναστολεις jak3 kai/ή jak1 | |
EA201790687A1 (ru) | Хинолинкарбоксамиды для применения в лечении множественной миеломы | |
EA201990952A1 (ru) | ПИРИДОНОВОЕ СОЕДИНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРА c-Met | |
MX2015013414A (es) | N-(2-ciano heterociclil)pirazolo piridonas como inhibidores de janus quinasa. | |
MA51285A (fr) | Dérivés d'azaindole comme inhibiteurs de rho-kinase | |
CY1123406T1 (el) | Παραγωγο τριαζολοπυραζινονης χρησιμο ως ενας ανθρωπινος pde1 αναστολεας | |
BR112017019176A2 (pt) | processos para a preparação de fluorocetolídeos | |
MX2018003903A (es) | Compuesto biciclico y uso del mismo para inhibicion de suv39h2. | |
MY182634A (en) | Pharmaceutical containing sodium-dependent phosphate transporter inhibitor | |
EA201791839A1 (ru) | Диметоксифенильные ингибиторы везикулярного транспортера моноаминов 2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM |